On the other hand, correlation analysis of PP1 and DARPP-32, which involves in cancer cell survival and drug resistance [578], depicted that that low expression of PP1 in samples with a higher level of DARPP-32 associated with adverse survival in breast cancer patients when compared to high expression in the same group [579]. The gene discussed is PPP1R1B; the disease is breast carcinoma.